Latest Tax Incentives News

Paradigm Biopharmaceuticals has strengthened its balance sheet with a combined $5.75 million cash inflow from Australian Government R&D tax incentives, supporting its pivotal Phase 3 osteoarthritis trial and regulatory efforts.

CONNEQT Health's June quarter saw record consumer revenue growth and a 70% jump in enterprise subscription ARR, supported by a $5.5 million placement and progress on its FDA regulatory pathway for its cloud-based vascular analytics platform.

Biotron has received pivotal regulatory feedback from the European Medicines Agency ruling out a Hybrid Marketing Authorisation for SedRx, prompting plans for pivotal clinical trials. The company also advances its lead antiviral candidate BIT-HBV001 against Hepatitis Delta Virus and appoints a new chairman.

AdNeo Limited achieved a record positive operating cash flow of $451k in Q4 FY26 and secured significant customer contracts, setting the stage for disciplined growth in FY27.

Norwood Systems lifted FY26 customer cash receipts to a record A$2.327 million, driven by multiple Tier-1 carrier contracts and successful AI pilot completions in Australia and the UK.

Hazer Group has completed a key commercial-scale hydrogen process design package with KBR, boosting its readiness for large-scale deployment and expanding its project pipeline across multiple sectors and geographies.

Neurotech International has locked in a $3.15 million secured loan against its anticipated R&D tax incentives to fund pivotal Phase III autism trials and ongoing operations.

Centaurus Metals has gained regulatory approval to connect its Jaguar Nickel Sulphide Project in Brazil to the national 230kV power grid, securing 20MW of low-cost, reliable electricity that will reduce operating costs and de-risk the project ahead of a Final Investment Decision.

Starpharma launches a fully underwritten $32 million entitlement offer to fund the Phase 1 trial of its DEP® HER2-Lutetium radiopharmaceutical and accelerate its targeted oncology asset development.

Elixir Energy’s Lorelle-3H appraisal well in Queensland’s Taroom Trough has completed its initial clean-up phase, delivering promising dual phase flow rates and preparing for a critical tubing run to stabilise production before resuming testing.

Impact Minerals (ASX:IPT) has received a $310,000 Research and Development tax rebate for FY2025, supporting its Lake Hope High Purity Alumina project and investment in Alluminous Pty Ltd.

Orthocell Ltd delivered a standout FY26 with 44% revenue growth to A$13.2 million, powered by accelerating US sales of its nerve repair product Remplir and a robust cash position supporting further expansion.